XHKG
0574
Market cap5mUSD
Jun 30, Last price
0.02HKD
Name
Pa Shun International Holdings Ltd
Chart & performance
P/E
—
P/S
0.39
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-28.81%
Revenues
87m
+0.29%
Net income
-16m
L+3.55%
CFO
-11m
L+530.56%
Dividend
Jun 06, 20160.03 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution and manufacturing businesses in the People's Republic of China. The company sells pharmaceutical products to wholesalers, hospitals, and other medical institutions in rural areas. It also sells pharmaceutical products manufactured by the company. The company was formerly known as Pa Shun Pharmaceutical International Holdings Limited and changed its name to Pa Shun International Holdings Limited in June 2017. The company was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Pa Shun International Holdings Limited operates as a subsidiary of Praise Treasure Limited.
Key people
Qinghai Ma
Chief Executive Officer, Executive Director · since 2024
Executive Chairman of the Board · since 2024
Xiaoduo Li
Manager - Manufacturing
Zaixiu Tang
Head - Accounting Department · since 2013
Company Secretary · since 2024
Zhongzheng Chen
Non-Executive Director · since 2024
Jinkai Zhou
Non-Executive Director · since 2024
Independent Non-Executive Director · since 2023
Yan Li
Independent Non-Executive Director · since 2023
Chun Yip Lowe
Independent Non-Executive Director · since 2024
Tung Yuen Wong
Independent Non-Executive Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||